ORIGINAL RESEARCH

Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents

About authors

Research Institute of Hygiene, Occupational Pathology and Human Ecology Leningrad Region, Russia

Correspondence should be addressed: Denis S. Laptev
st. Kapitolovo, gor. pos. Kuzmolovsky, 93, Vsevolozhsky rajon, 188663; ur.liam@nedpal

About paper

Author contribution: Laptev DS — experimental part, information collection, data processing; Petunov SG — data processing and interpretation, general guidance; Nechaykina OV — experimental part, information collection; Bobkov DV — data processing; Radilov AS — data processing and interpretation.

Compliance with ethical standards: all work with animals was carried out in conformity to the provisions of the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes.

Received: 2020-09-15 Accepted: 2020-12-25 Published online: 2020-12-12
|
  1. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017; 39: 529–39. DOI: 10.1007/s00281-017-0629-x.
  2. Su S, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016; 24 (6): 490–502. DOI: 10.1016/j.tim.2016.03.003.
  3. Gu J, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005; 202 (3): 415–24. DOI: 10.1084/jem.20050828.
  4. Nicholls JM, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003; 361 (9371): 1773–8. DOI: 10.1016/ S0140-6736(03)13413-7.
  5. Akhmerov A, Marban E. COVID-19 and the Heart. Circ Res. 2020; 126 (10): 1443–55. DOI: 10.1161/circresaha.120.317055.
  6. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 811–8. DOI: 10.1001/jamacardio.2020.1017.
  7. Li J, Benashski SE, Venna VR, McCullough LD. Effects of metformin in experimental stroke. Stroke. 2010; 41: 2645–52.
  8. Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016; 118: 496–514. DOI: 10.1161/CIRCRESAHA.115.306573.
  9. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5 (7): 802–10. DOI: 10.1001/jamacardio.2020.0950.
  10. Gundewar S, Calvert JW, Jha S, Toedt_Pingel I, Ji SY, Nunez D, et al. Activation of AMP activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009; 104: 403–11.
  11. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, et al. Mechanism of action of A769662, a valuable tool for activation of AMP activated protein kinase. J Biol Chem. 2007; 282: 32549–60.
  12. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, et al. Activation of GLUT1 by metabolic and osmotic stress: potential involve ment of AMP activated protein kinase (AMPK). J Cell Sci. 2002; 115: 2433–42.
  13. Procopio C, Andreozzi F, Laratta E, Cassese A, Beguinot F, Arturi F, et al. Leptin stimulated endothelial nitric oxide synthase via an adenosine 5' monophosphate activated protein kinase/Akt signaling pathway is attenuated by interaction with C reactive protein. Endocrinology. 2009; 150: 3584–93.
  14. Nelson K, Bobba C, Eren E, Spata T, Tadres M, Hayes DJr, et al. Method of isolated ex vivo lung perfusion in a rat model: lessons learned from developing a rat EVLP program. J Vis Exp. 2015; 25 (96): 52309. DOI: 10.3791/52309.
  15. Chianga C, Pai H, Liu S. Ventilator-induced lung injury (VILI) promotes ischemia/reperfusion lung injury (I/R) and NF-kB antibody attenuates both injuries. Resuscitation. 2008; 79: 147–154.
  16. Ishikita A, Matoba T, Ikeda G, Koga JI, Mao Y, Nakano K, et al. Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia- Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction. J Am Heart Assoc. 2016; 5 (7): e003872. DOI: 10.1161/JAHA.116.003872.
  17. Kim AS, Miller EJ, Wright TM, Li J, Qi D, Atsina K, et al. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury. J Mol Cell Cardiol. 2011; 51: 24–32.